Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review)
International Journal of Oncology · 18.02.2025 · 66 (4) · 1-22
DOI: 10.3892/ijo.2025.5732 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 18.02.2025. Verfasst von Xiaohu Ouyang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technol…. Hauptthemen laut MEDLINE: Neoplasms, Heme Oxygenase-1, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 244 Literaturangaben.
Abstract (Originalsprache)
Malignant tumors are non-communicable diseases that impact human health and quality of life. Identifying and targeting the underlying genetic drivers is a challenge. Heme oxygenase-1 (HO-1), a stress-inducible enzyme also known as heat shock protein 32, plays a crucial role in maintaining cellular homeostasis. It mitigates oxidative stress-induced damage and exhibits anti-apoptotic properties. HO-1 is expressed in a wide range of malignancies and is associated with tumor growth. However, the precise role of HO-1 in tumor development remains controversial. Drugs, both naturally occurring and chemically synthesized, can inhibit tumor growth by modulating HO-1 expression in cancer cells. The present review aimed to discuss biological functions of HO-1 pharmacological therapies targeting HO-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
- Health Management Center, Hubei Provincial Hospital of Integrated Chinese & Western Medicine, Wuhan, Hubei 430015, P.R. China.
Zitieren
APA
Ouyang, X., Wang, J., Qiu, X., Hu, D., & Cui, J. (2025). Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review). International Journal of Oncology, 66(4), 1-22. https://doi.org/10.3892/ijo.2025.5732
Vancouver
Ouyang X, Wang J, Qiu X, Hu D, Cui J. Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review). International Journal of Oncology. 2025;66(4):1-22. doi:10.3892/ijo.2025.5732
BibTeX
@article{Ouyang2025,
author = {Ouyang, Xiaohu and Wang, Jingbo and Qiu, Xiaoyuan and Hu, Desheng and Cui, Jing},
title = {Current developments of pharmacotherapy targeting heme oxygenase 1 in cancer (Review)},
journal = {International Journal of Oncology},
year = {2025},
volume = {66},
number = {4},
pages = {1--22},
doi = {10.3892/ijo.2025.5732}
}
EUVIMED